eMass A Computer assisted Tumor Response Assessment Tool for Oncological Clinical Trials1459868571
Conducting manual reads for tumor-response in clinical trials is a slow process, and data measurement and transfer is prone to error. eMass (electronic Mass) is ...
imageiq
IDDI WEBINAR: Tumor-size based measurements as endpoint in cancer clinical trials
Given the expected direct cytotoxicity of chemotherapy, tumor shrinkage has been used as a proxy for anticancer activity since the early days of clinical cancer ...
IDDI
How should we use a Deauville score when employing PET imaging for our lymphoma patients?
In this presentation from the 2017 Great Debates & Updates in Hematologic Malignancies, Dr. Nancy L. Bartlett outlines the criterion and adoption of the ...
ImedexCME
Cancer Revealed: How the Immune System Sees and Destroys Tumors, with Jeffrey Weber
On June 16, 2015, Jeffrey S. Weber, M.D., Ph.D., discussed the cancer immunity cycle and the importance of antigen release and presentation to maximize the ...
Cancer Research Institute
Profiling Tumor Infiltrating Lymphocytes (TIL) with immunoSEQ®
Catherine Sanders, PhD, explains the cancer immunity cycle and how immunoSEQ(R) Assays are being used in research to better understand the role of ...
Adaptive Biotechnologies
Debate: Complete Response in Rectal Cancer? - Watchful Waiting
Earn CME for related activities: https://www.naccme.com/oln In this webcast from the '2019 ESMO World Congress on Gastrointestinal Cancer', Dr. Rodrigo O.
ImedexCME
Management of GIST tumors
Earn CME for related activities: https://www.naccme.com/oln There have been tremendous advancements in the multidisciplinary management of GI cancers in ...
ImedexCME
How accurate is RECIST 1.1 for assessing tumor response?
Get more analysis and radiology-related information and updates at https://caferoentgen.com/ The article discussed in the video are available at the following ...
The Cafe Roentgen 'Journal Watch'
Cancer Neoantigens as Targets for Natural and Therapeutic Anti-Tumor Responses
This webinar, presented by Dr. Robert Schreiber, addresses how mouse and human cancers have been used to identify therapeutically useful tumor ...
BioLegend
Tumour mutational burden and its transition towards the clinic
Prof. Dr. Wolfram Jochum from Institut für Pathologie, Kantonsspital St. Gallen discusses tumour mutational burden and its transition towards the clinic.
Thermo Fisher Scientific
Tumor Microenvironment Metabolism: effects on anti-tumor and pro-tumor immunity
Greg M. Delgoffe, PhD, Assistant Professor, Immunology, University of Pittsburgh Yale Center for Immuno-Oncology Dean's Symposium Advancements in ...
Yale Cancer Center
Targeting Cancer Pathways: Tumor Metabolism and Proliferation
Participating Experts: M. Celeste Simon, PhD (U. Penn) and Nissim Hay, PhD (U. Illinois). ⬇️ Expand “Show More” to view abstract and table of contents View ...
Cell Signaling Technology, Inc.
ctDNA, a Biomarker of Residual Disease and Tumor Response in Gastrointestinal Cancers
Monitoring ctDNA is a promising new approach to personalized cancer medicine that may provide real-time information about the evolution of tumors.
The Society for Translational Oncology
Novel MRI Assessment of Mesothelioma Tumor Volume
Kevin G. Blyth, MD, MBchB, FRCP 8th International Symposium on Malignant Pleural Mesothelioma.
Pacific Heart, Lung & Blood Institute
Imaging in rectal cancer
This Congress is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to ...
ImedexCME
1.2 Solid Tumors
Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute
Management of squamous cell cancer for the esophagus - Definitive CRT
In this presentation from the ESMO 20th World Congress on Gastrointestinal Cancer, Dr. David H. Ilson argues in favor of definitive CRT for the managemetn of ...
ImedexCME
Surgical Oncology for Gastrointestinal Stromal Tumors (GIST): Ask Dr. Waddah Al-Refaie
Dr. Waddah Al-Refaie answers commonly asked questions about Gastrointestinal Stromal Tumors (GIST), including what causes GIST and how it is treated.
MedStar Georgetown University Hospital
Recommendation on the management of synchronous/metachronous liver metastases
This Congress is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to ...
ImedexCME
Colorectal Cancer: MSI Testing to All Patients and How to Test
Earn CME for related activities: https://www.naccme.com/oln In this webcast from the '2019 ESMO World Congress on Gastrointestinal Cancer', Dr. Magali ...
ImedexCME
Organ sparing-surgery in rectal cancer: How important is it? How can we progress with it?
Drs. Mario Dicato and Eric Van Cutsem, along with Dr. Josep Tabernero, chaired the ESMO 15th World Congress on Gastrointestinal Cancer which was held in ...
ImedexCME
Evaluation of Early-Stage Hepatocellular Carcinoma by Magnetic Resonance Imaging With...
Dr. Hyung-Don Kim discusses his manuscript "Evaluation of Early-Stage Hepatocellular Carcinoma by Magnetic Resonance Imaging With Gadoxetic Acid ...
AmerGastroAssn
Use of PET Scan in Hodgkin Lymphoma
Drs Sweetenham, Chen, and Younes discuss the use of PET scans as a treatment response assessment tool in Hodgkin lymphoma.
OncLiveTV
Multidisciplinary Tumor Board: A Challenging Patient With Colorectal Cancer
Earn CME for related activities: https://www.naccme.com/oln In this webcast from the '2019 ESMO World Congress on Gastrointestinal Cancer', the Colorectal ...
ImedexCME
How to score the PD-L1 (SP263) Assay in Urothelial Carcinoma
US Medical and Scientific Affairs (MSA) pathologist Dr. Erin Marner provides an overview of the PD-L1 (SP263) Assay by reviewing two urothelial carcinoma ...
RocheDiagnosticsUSA
Gordan Freeman-PD-1 cancer immunotherapy
Watch this webinar on Labroots at http://www.labroots.com/virtual-event/cancer-research-2016#gordon_j_freeman The immune system is capable of ...
LabRoots
Cancer cachexia and sarcopenia in GI cancer: Mechanism and ways to interfere with it
The ESMO World Congress on Gastrointestinal Cancer is the premier annual event in gastrointestinal cancer. At this year's meeting, experts from around the ...
ImedexCME
Controversy Debate 2: Selecting optimal treatments for esophagus cancer - Whom to operate upon?
The ESMO World Congress on Gastrointestinal Cancer is the premier annual event in gastrointestinal cancer. At this year's meeting, experts from around the ...
ImedexCME
Update on the treatment of GIST
In this presentation from the Great Debates in Gastrointestinal Malignancies 2018 conference, Dr. Thorvardur Halfdanarson provides an update on the ...
ImedexCME
Neuropsychological Issues Related to Brain Tumors
Support Group Facilitator Training Presentation by Kathleen L. Fuchs, Ph.D. ABPP “Neuro-psychological Issues Related to Brain Tumors” discusses how brain ...
American Brain Tumor Association
Acute Kidney Injury (Part 2/3 - Diagnostic Evaluation)
A review of the labs and other data that are used to identify the etiology of AKI, including BUN:Cr ratio, FENa, FEurea, urinalysis, post-void residual (PVR), and ...
Strong Medicine
Thyroid Cancer: Lymph Node Evaluation & Mapping, Pre- & Post-Operative. Dr. Patel. ThyCa Conference
A Discussion of Lymph Node Evaluation in the Setting of Thyroid Cancer: Pre- and Post-Operative Nodal Mapping and Assessment. Nayana Patel, M.D. ...
ThyCa: Thyroid Cancer Survivors' Association, Inc.
Right- Versus Left-Sided Colorectal Tumors and Survival
Panelists John L. Marshall, MD; Tanios Bekaii-Saab, MD; Cathy Eng, MD; and Daniel G. Haller, MD, outline the differences in right-sided versus left-sided tumors ...
OncLiveTV
Restoring effective anti-tumor response in Hodgkin lymphoma with nivolumab
Press brief by Anas Younes, MD of the Memorial Sloan Kettering Cancer Center, New York, NY, at the 2016 Annual Meeting of the European Association of ...
VJHemOnc – Video Journal of Hematological Oncology
ASCO 2019: Dr. Horn Highlights Progress in Lung Cancer
Leora Horn, MD, associate professor of medicine (hematology and oncology), assistant director, educator development program, clinical director, Thoracic ...
OncLiveTV
Debate: Best second line therapy for relapsed Hodgkin lymphoma - Brentuximab alone/+ chemo
In this presentation from the 2017 Great Debates & Updates in Hematologic Malignancies, Dr. Ann S. LaCasce argues that the best pre-transplant second line ...
ImedexCME
Genetics in pancreatic cancer: Implications for clinical practice
In this presentation from the ESMO 20th World Congress on Gastrointestinal Cancer, Dr. Zsofia K. Stadler discusses genetics in pancreatic cancer, and outlines ...
ImedexCME
An Approach to Acute Dyspnea
An overview of the diagnostic approach to the acute onset of shortness of breath.
Strong Medicine
What You Need to Know About Colon Cancer
One of the most common cancers in the United States, colorectal cancer most often occurs in men and women over age 50 or in those with a family history.
Stanford Health Care
Understanding the Link Between Scleroderma and Cancer- Laura K. Hummers, M.D., Sc.M.- 2018
While studies have suggested that the risk of cancer might be increased in scleroderma patients, the reason for this association has not been well understood.
Scleroderma Foundation
Update in primary CNS lymphoma management
The continued evolution and refinement of strategies for disease diagnosis, risk assessment, therapeutic intervention and disease management have provided ...
ImedexCME
Locally Advanced HER2+ Breast Cancer
Locally Advanced HER2+ Breast Cancer highlights a case presentation of a patient with HER2-positive early-stage/locally advanced disease. The webcast ...
ClevelandClinicCME
